ClinicalTrials.gg
CompletedNCT07107113Updated Jan 8, 2026

Pilates and Aerobic Training on Cardiorespiratory Fitness, Flexibility, Strength, and Muscular Power in Young Adults

An interventional study of Pilates Exercise and Aerobic exercises in Improvement of Cardiorespiratory Fitness, Flexibility, Strength and Muscle Power in Healthy Participants, sponsored by Universidade Estadual do Norte do Parana. Completed at 1 site in Brazil. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-08.

Sponsored by Universidade Estadual do Norte do Parana · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Pilates exercises have been shown to be effective for a range of outcomes; however, it is unclear whether they can effectively contribute to improving cardiorespiratory fitness, especially when compared with aerobic training, which is known to be effective for this purpose. Furthermore, the differences between these modalities for outcomes such as flexibility, strength, and muscular power require further investigation. Therefore, the objective of this study is to assess the effectiveness of Pilates compared to aerobic training, as well as the combination of these activities, on cardiorespiratory fitness, flexibility, strength, and muscular power in young adults. Eighty women aged 18 to 40 will be randomized to four groups: Pilates (n = 20), aerobic (n = 20), Pilates plus aerobic (n = 20), and control (n = 20). Cardiorespiratory fitness will be assessed directly to estimate V̇O2max. Trunk flexibility in flexion and extension will be measured with a fleximeter (°). Lower-limb, upper-limb, and trunk muscle strength will be assessed by isokinetic dynamometry (N.m), while lower-limb muscle power (W) will be assessed by countermovement jumping on a force platform. Interventions will be conducted for 12 weeks, three times a week, with a 60-minute session duration. Analyses will be conducted by intention-to-treat and per-protocol.

02

Conditions studied

  • Improvement of Cardiorespiratory Fitness, Flexibility, Strength and Muscle Power in Healthy Participants
03

In context

Lead sponsor

Universidade Estadual do Norte do Parana is the lead sponsor of 12 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • female;
  • age between 18 and 40 years; - not having exercised in the last 6 months;
  • agreeing not to perform any other type of exercise during the study period;
  • being fit to exercise according to the Physical Activity Readiness Questionnaire (PAR-Q) criteria;
  • having no musculoskeletal or neurological disorders that could affect exercise performance;
  • having no known cardiovascular or respiratory diseases;
  • having no cognitive impairment that could lead to the inability to follow simple commands;
  • not being a smoker;
  • not being pregnant;
  • not being on any specific diets.

Exclusion criteria

Exclusion Criteria:

  • refusing to sign the form;
  • being unable to complete the pre-intervention assessment procedures.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    Pilates

    A total of 13 exercises were selected for the Pilates group, including two stretching exercises and 11 strengthening exercises for the main muscle groups. Mat exercises and equipment exercises (Ladder Barrel, Cadillac, Step Chair, Reformer, Springboard, and Small Barrel) will be used. Two protocols will be adopted for progression (protocol 1: weeks 1-6; protocol 2: weeks 7-12). Two sets of 10 repetitions will be performed, with a 30-second rest between sets and exercises. The two-by-two rule will be used to increase the load. In this case, the load will increase when the participant performs ≥ 2 repetitions above their target of 10 repetitions in the last set, in two consecutive training sessions. The interventions will last 12 weeks, three times a week, for 60 minutes.

    Other: Pilates Exercise

  • Experimental
    Aerobic

    The aerobic group will perform walking/running exercises on a treadmill, using the extensive interval training method. To define the intensity and periodization of the training, the running speed associated with V̇O2max (vV̇O2max), second ventilatory threshold (vLV2), and average speed between vV̇O2max and vLV2 (v50%Δ) will be used as a reference. These parameters will be obtained from a maximal exercise test on a treadmill, performed before the start of the interventions. Two protocols will be adopted, with adjustments in density (work-to-recovery ratio) every two weeks. The interventions will last 12 weeks, three times a week, for 60 minutes.

    Other: Aerobic exercises

  • Experimental
    Pilates plus aerobic

    They will perform the same exercises as the Pilates group, however, with 1 set of 10 repetitions, with a 30-second rest between sets and exercises, totaling 30 minutes of intervention per session. In the second half of the intervention period, aerobic exercises will be performed, identical to those of the aerobic group, but for 30 minutes. The interventions will last 12 weeks, three times a week, for 60 minutes.

    Other: Pilates exercises plus aerobic exercise

  • No intervention
    Control

    This group will be instructed to maintain their usual routine.

Interventions

  • OtherPilates Exercise

    Pilates exercises are characterized as muscle strengthening and stretching.

  • OtherAerobic exercises

    Aerobic exercises are characterized as a modality that works cardiorespiratory fitness.

  • OtherPilates exercises plus aerobic exercise

    Pilates exercises are characterized as muscle strengthening and stretching, while aerobic exercises are characterized as a modality that works cardiorespiratory fitness.

06

What researchers measure

Primary outcomes

  1. Cardiorespiratory Fitness

    Maximum volume of oxygen obtained directly from inhaled and exhaled gases (V̇O2max) in a maximum incremental treadmill test.

    Time frame: Baseline and after 12 weeks

Secondary outcomes

  1. Flexibility

    Range of motion measured with a fleximeter (º) for trunk movement in flexion and extension.

    Time frame: Baseline and after 12 weeks

  2. Trunk muscle strength

    Peak isokinetic torque of the trunk extensor and flexor muscles (cocentric/concentric) at 60°/s.

    Time frame: Baseline and after 12 weeks

  3. Lower limb muscle strength

    Peak isokinetic torque of the knee extensor and flexor muscles (cocentric/concentric) at 60°/s.

    Time frame: Baseline and after 12 weeks

  4. Upper limb muscle strength

    Peak isokinetic torque of the elbow extensor and flexor muscles (cocentric/concentric) at 60°/s.

    Time frame: Baseline and after 12 weeks

  5. Lower limb muscle power

    Lower limb muscle power (W) measured by countermovement jump on a force plate.

    Time frame: Baseline and after 12 weeks

07

Study locations

1 site
  • Universidade Estadual do Norte do Paraná
    Jacarezinho, Paraná 86400-000, Brazil
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data will be provided as supplementary material upon publication of the study results.

Supporting information: Statistical analysis plan

Time frame: From September 1, 2025, until the date of publication of the study.

Access criteria: The information will be freely accessible.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2025 to primary completion in Dec 2025, 4 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 30, 2025
First posted
Aug 6, 2025
StartActual
Aug 10, 2025
Primary completionActual
Dec 10, 2025
CompletionActual
Dec 10, 2025
Last update
Jan 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07107113
Lead sponsor
Universidade Estadual do Norte do Parana
Responsible party
Raphael Goncalves de Oliveira (Professor, Universidade Estadual do Norte do Parana) — Principal investigator
First posted
Aug 6, 2025
Start date
Aug 10, 2025
Primary completion
Dec 10, 2025
Completion
Dec 10, 2025
Last update
Jan 8, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion